Concepedia

Jingjin Li

JL

53

Publications

4.3K

Citations

27

H-Index

2001

Active since

Affiliations

Regeneron (United States)(Current)

Nanjing Medical University

Peking University

The University of Texas MD Anderson Cancer Center

Huazhong Agricultural University

Jingjin Li is an author at Regeneron (United States) specializing in medicine, immunology, and pharmacology.

Top concepts

MedicineImmunologyHealthPharmacologyPublic HealthPathologyRadiologyPhysiologyInflammationCell Signaling

Publications per year

2001–2023

53

Publications

53

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma

Michael R. Migden, Danny Rischin, Chrysalyne D. Schmults et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Martin Grießhammer et al. · New England Journal of Medicine · 2015 · 851 citations

A compendium and comparative epigenomics analysis of cis-regulatory elements in the pig genome

Yunxia Zhao, Ye Hou, Yueyuan Xu et al. · Nature Communications · 2021 · 194 citations · Full text

Factors Associated with Drug Adherence and Blood Pressure Control in Patients with Hypertension

Andrew B. Morris, Jingjin Li, Kurt Kroenke et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 2006 · 154 citations

Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer

Nicoletta Colombo, E. Kutarska, Meletios Α. Dimopoulos et al. · Journal of Clinical Oncology · 2012 · 120 citations

Rows per page

1–5 of 53